Second-Line Antiretroviral Therapy for Children Living with HIV in Africa

Second-line ART regimens including TAF-emtricitabine and dolutegravir were effective for children, with no evidence of safety concerns. Ritonavir-boosted darunavir was also effective. (Funded by the European and Developing Countries Clinical Trials Partnership and others; CHAPAS-4 ISRCTN Registry number, ISRCTN22964075.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-05-14
DOI
https://doi.org/10.1056/nejmoa2404597
Citations
14
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
19.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Second-Line Antiretroviral Therapy for Children Living with HIV in Africa

Simon Walker, A. Sarah Walker, Kusum Nathoo, Khozya Zyambo et al.
14 citations
New England Journal of Medicine
HIV/AIDS Research and Interventions
19.55
article

Second-Line Antiretroviral Therapy for Children Living with HIV in Africa

Simon Walker, A. Sarah Walker, Kusum Nathoo, Khozya Zyambo, Veronica Mulenga, Alexander J. Szubert, Kevin Zimba, Anna Turkova, David Burger, Clare Shakeshaft, Godfrey Musoro, Helen McIlleron, Alasdair Bamford, Diana M. Gibb, Shafic Makumbi, Vivian Mumbiro, Eva Natukunda, Hilda Mujuru, Yingying Zhang, Cissy Kityo, Rashidah Nazzinda, Annabelle South, Mutsa Bwakura‐Dangarembizi, Wedu Ndebele, Katja Doerholt, Bwendo Nduna, Lara Monkiewicz, Mwate Mwamabazi, Ibrahim Yawe, Kyomuhendo Jovia Linda, Chishala Chabala, Monica Kapasa, Joyce Lungu, Anna Griffiths, Victor Musiime, Mary Nyathi, Abbas Lugemwa
article en
14 citations

Abstract

Second-line ART regimens including TAF-emtricitabine and dolutegravir were effective for children, with no evidence of safety concerns. Ritonavir-boosted darunavir was also effective. (Funded by the European and Developing Countries Clinical Trials Partnership and others; CHAPAS-4 ISRCTN Registry number, ISRCTN22964075.).

New England Journal of MedicineVol. 392(19)
Radboud University Nijmegen (NL), University of Zimbabwe (ZW), University of Cape Town (ZA), Great Ormond Street Hospital (GB), Mpilo Central Hospital (ZW), University Teaching Hospital (ZM), Radboud University Medical Center (NL), National University of Science and Technology (ZW), University of Zambia (ZM), Infectious Diseases Research Collaboration (UG), Joint Clinical Research Centre (UG), University College London (GB), University of York (GB), Makerere University (UG), Medical Research Council (GB)
Gilead Sciences, Medical Research Council, Janssen Pharmaceuticals, European and Developing Countries Clinical Trials Partnership
Good health and well-being
Openalex Percentile: Top 0%
HIV/AIDS Research and Interventions
19.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.